SRSF6 and familial pancreatic carcinoma: Upregulation of miR-193a-5p (also a regulator of SRSF2 described previously) directly targets and inhibits SRSF6, and as a result, the splice variants of OGDHL and ECM1 conducive to tumorigenicity are expressed in pancreatic cancer [34].